Broad and Bayer to build heart failure datasets

06-07-2018

Broad and Bayer to build heart failure datasets

nadla / iStockphoto.com

The Broad Institute of Harvard and MIT has expanded its partnership with German pharmaceutical company Bayer to develop new therapies for heart failure.


The Broad Institute of Harvard and MIT, Bayer, heart failure, partnership, therapies, cardiology, datasets, single cell sequencing, drug development

LSIPR